Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Modulation of mGlu5 receptor activity may provide benefit in incontinence and overactive bladder

Sep. 4, 2007

Plans delayed for phase III study of bremelanotide for ED

Sep. 3, 2007

Recent Takeda patent reports novel tachykinin NK1 antagonists

Sep. 3, 2007

Orexo's treatment for nocturia/incontinence enters phase I

Aug. 31, 2007

BioLineRx Inlicenses acute kidney injury treatment

Aug. 30, 2007

SVT-40776 increases voiding volume in healthy postmenopausal women

Aug. 30, 2007

New serotonin receptor antagonist for the treatment of incontinence described by Recordati

Aug. 29, 2007

Effect of KRP-204 on C-fiber urethral afferent nerves suggests benefit in urgency

Aug. 29, 2007

Pooled data show dose-related efficacy of fesoterodine in overactive bladder

Aug. 29, 2007

Experimental evidence points to besipirdine efficacy in urinary incontinence

Aug. 28, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...